Coexpression cluster:C1218
From FANTOM5_SSTAR
Full id: C1218_hairy_plasma_lymphoma_xeroderma_hereditary_mycosis_splenic
Phase1 CAGE Peaks
Hg19::chr16:29656517..29656522,- | p@chr16:29656517..29656522 - |
Hg19::chr1:32716592..32716596,+ | p5@LCK |
Hg19::chr20:52675557..52675561,- | p4@BCAS1 |
Hg19::chr4:36334205..36334210,- | p@chr4:36334205..36334210 - |
Hg19::chr6:109196481..109196488,+ | p@chr6:109196481..109196488 + |
Hg19::chr6:160351875..160351879,- | p@chr6:160351875..160351879 - |
Hg19::chr8:101512336..101512341,- | p@chr8:101512336..101512341 - |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0042610 | CD8 receptor binding | 0.00549074903622083 |
GO:0050862 | positive regulation of T cell receptor signaling pathway | 0.00549074903622083 |
GO:0042609 | CD4 receptor binding | 0.00549074903622083 |
GO:0051117 | ATPase binding | 0.00549074903622083 |
GO:0006882 | cellular zinc ion homeostasis | 0.00549074903622083 |
GO:0055069 | zinc ion homeostasis | 0.00549074903622083 |
GO:0043548 | phosphoinositide 3-kinase binding | 0.00549074903622083 |
GO:0001948 | glycoprotein binding | 0.00549074903622083 |
GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway | 0.00549074903622083 |
GO:0000242 | pericentriolar material | 0.00549074903622083 |
GO:0050856 | regulation of T cell receptor signaling pathway | 0.00549074903622083 |
GO:0051283 | negative regulation of sequestering of calcium ion | 0.00575204393640925 |
GO:0051282 | regulation of sequestering of calcium ion | 0.00575204393640925 |
GO:0051209 | release of sequestered calcium ion into cytosol | 0.00575204393640925 |
GO:0051208 | sequestering of calcium ion | 0.00629111284022556 |
GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 0.00629111284022556 |
GO:0051238 | sequestering of metal ion | 0.00769702166833902 |
GO:0050852 | T cell receptor signaling pathway | 0.0095055909313886 |
GO:0042169 | SH2 domain binding | 0.00953487963183759 |
GO:0044450 | microtubule organizing center part | 0.0115734324519592 |
GO:0050851 | antigen receptor-mediated signaling pathway | 0.0129384792222954 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 0.0132823318112429 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 0.0132823318112429 |
GO:0002757 | immune response-activating signal transduction | 0.0132823318112429 |
GO:0002764 | immune response-regulating signal transduction | 0.0132823318112429 |
GO:0004715 | non-membrane spanning protein tyrosine kinase activity | 0.0142244370855518 |
GO:0050870 | positive regulation of T cell activation | 0.0142244370855518 |
GO:0030217 | T cell differentiation | 0.0142244370855518 |
GO:0051235 | maintenance of localization | 0.0142244370855518 |
GO:0006919 | caspase activation | 0.0149284042553036 |
GO:0045121 | lipid raft | 0.0149284042553036 |
GO:0043280 | positive regulation of caspase activity | 0.0155468175678466 |
GO:0051251 | positive regulation of lymphocyte activation | 0.0155468175678466 |
GO:0050863 | regulation of T cell activation | 0.0172038426275883 |
GO:0043281 | regulation of caspase activity | 0.0172038426275883 |
GO:0042493 | response to drug | 0.0172038426275883 |
GO:0030098 | lymphocyte differentiation | 0.0172038426275883 |
GO:0004722 | protein serine/threonine phosphatase activity | 0.0172038426275883 |
GO:0051480 | cytosolic calcium ion homeostasis | 0.0173694565847348 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 0.0173694565847348 |
GO:0002253 | activation of immune response | 0.0173694565847348 |
GO:0008022 | protein C-terminus binding | 0.0173694565847348 |
GO:0051345 | positive regulation of hydrolase activity | 0.0173694565847348 |
GO:0051249 | regulation of lymphocyte activation | 0.0173694565847348 |
GO:0050865 | regulation of cell activation | 0.0178762817634228 |
GO:0019901 | protein kinase binding | 0.0180143473637898 |
GO:0050778 | positive regulation of immune response | 0.0180143473637898 |
GO:0002684 | positive regulation of immune system process | 0.0180143473637898 |
GO:0008632 | apoptotic program | 0.0180970681862679 |
GO:0002521 | leukocyte differentiation | 0.0180970681862679 |
GO:0050776 | regulation of immune response | 0.0186156389784673 |
GO:0042110 | T cell activation | 0.0186156389784673 |
GO:0019900 | kinase binding | 0.0186156389784673 |
GO:0002682 | regulation of immune system process | 0.0186156389784673 |
GO:0051240 | positive regulation of multicellular organismal process | 0.0191896170851969 |
GO:0006874 | cellular calcium ion homeostasis | 0.0204527827727977 |
GO:0055074 | calcium ion homeostasis | 0.0204527827727977 |
GO:0006875 | cellular metal ion homeostasis | 0.0209496874891393 |
GO:0055065 | metal ion homeostasis | 0.0209496874891393 |
GO:0019904 | protein domain specific binding | 0.0212493622807121 |
GO:0005813 | centrosome | 0.0212493622807121 |
GO:0005815 | microtubule organizing center | 0.0238175112989571 |
GO:0046649 | lymphocyte activation | 0.0247121557886227 |
GO:0030097 | hemopoiesis | 0.025265444591113 |
GO:0048534 | hemopoietic or lymphoid organ development | 0.0266282153137071 |
GO:0045321 | leukocyte activation | 0.0266282153137071 |
GO:0030005 | cellular di-, tri-valent inorganic cation homeostasis | 0.0266282153137071 |
GO:0002520 | immune system development | 0.0266282153137071 |
GO:0055066 | di-, tri-valent inorganic cation homeostasis | 0.0266282153137071 |
GO:0030003 | cellular cation homeostasis | 0.0286789366588777 |
GO:0055080 | cation homeostasis | 0.0286978621515081 |
GO:0001775 | cell activation | 0.0288865464751273 |
GO:0006917 | induction of apoptosis | 0.0288865464751273 |
GO:0012502 | induction of programmed cell death | 0.0288865464751273 |
GO:0055082 | cellular chemical homeostasis | 0.0312844536056327 |
GO:0006873 | cellular ion homeostasis | 0.0312844536056327 |
GO:0043085 | positive regulation of catalytic activity | 0.0327530472383582 |
GO:0043065 | positive regulation of apoptosis | 0.0327530472383582 |
GO:0043068 | positive regulation of programmed cell death | 0.0327530472383582 |
GO:0050801 | ion homeostasis | 0.0334674497335767 |
GO:0051239 | regulation of multicellular organismal process | 0.0342871919098899 |
GO:0048878 | chemical homeostasis | 0.0361962874839148 |
GO:0019899 | enzyme binding | 0.0361962874839148 |
GO:0004713 | protein-tyrosine kinase activity | 0.0361962874839148 |
GO:0051336 | regulation of hydrolase activity | 0.0361962874839148 |
GO:0004721 | phosphoprotein phosphatase activity | 0.0364713582468456 |
GO:0019725 | cellular homeostasis | 0.0431538693944755 |
GO:0007265 | Ras protein signal transduction | 0.0491068728919253 |
GO:0016791 | phosphoric monoester hydrolase activity | 0.0492251115653811 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|---|---|
lymphocyte of B lineage | 4.79e-33 | 24 |
pro-B cell | 4.79e-33 | 24 |
lymphocyte | 5.12e-25 | 53 |
common lymphoid progenitor | 5.12e-25 | 53 |
nucleate cell | 5.55e-24 | 55 |
lymphoid lineage restricted progenitor cell | 2.37e-22 | 52 |
precursor B cell | 1.87e-18 | 3 |
mature B cell | 3.28e-13 | 2 |
pre-B-II cell | 3.28e-13 | 2 |
transitional stage B cell | 3.28e-13 | 2 |
small pre-B-II cell | 3.28e-13 | 2 |
immature B cell | 3.28e-13 | 2 |
hematopoietic cell | 3.27e-11 | 177 |
nongranular leukocyte | 1.37e-09 | 115 |
circulating cell | 4.27e-09 | 6 |
leukocyte | 9.47e-09 | 136 |
hematopoietic stem cell | 1.79e-08 | 168 |
angioblastic mesenchymal cell | 1.79e-08 | 168 |
hematopoietic oligopotent progenitor cell | 6.61e-08 | 161 |
hematopoietic multipotent progenitor cell | 6.61e-08 | 161 |
hematopoietic lineage restricted progenitor cell | 7.95e-08 | 120 |
antibody secreting cell | 1.55e-07 | 1 |
plasma cell | 1.55e-07 | 1 |
plasmablast | 1.55e-07 | 1 |
B-1 B cell | 2.37e-07 | 1 |
CD34-positive, CD38-negative hematopoietic stem cell | 3.60e-07 | 1 |
Ontology term | p-value | n |
---|---|---|
lymph node | 2.52e-07 | 1 |
Ontology term | p-value | n |
---|---|---|
lymphoma | 1.41e-36 | 10 |
hematologic cancer | 3.07e-14 | 51 |
immune system cancer | 3.07e-14 | 51 |
anemia | 1.65e-07 | 1 |
non-Hodgkin lymphoma | 1.75e-07 | 1 |
cutaneous T cell lymphoma | 1.75e-07 | 1 |
mycosis fungoides | 1.75e-07 | 1 |
lymphatic system cancer | 2.37e-07 | 1 |
lymphosarcoma | 2.37e-07 | 1 |
genetic disease | 3.01e-07 | 1 |
monogenic disease | 3.01e-07 | 1 |
xeroderma pigmentosum | 3.01e-07 | 1 |
acute leukemia | 4.57e-07 | 1 |
papillary adenocarcinoma | 4.85e-07 | 1 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.00215847 |
MA0004.1 | 0.502801 |
MA0006.1 | 0.341337 |
MA0007.1 | 0.483857 |
MA0009.1 | 0.973289 |
MA0014.1 | 0.0156227 |
MA0017.1 | 0.380797 |
MA0019.1 | 0.652951 |
MA0024.1 | 0.867125 |
MA0025.1 | 1.10816 |
MA0027.1 | 2.59001 |
MA0028.1 | 0.35747 |
MA0029.1 | 0.886702 |
MA0030.1 | 0.875089 |
MA0031.1 | 0.809638 |
MA0038.1 | 0.60704 |
MA0040.1 | 0.892629 |
MA0041.1 | 0.521615 |
MA0042.1 | 0.48922 |
MA0043.1 | 0.973609 |
MA0046.1 | 0.962263 |
MA0048.1 | 0.120314 |
MA0050.1 | 0.490116 |
MA0051.1 | 1.46692 |
MA0052.1 | 0.896548 |
MA0055.1 | 0.0407081 |
MA0056.1 | 0 |
MA0057.1 | 0.115382 |
MA0058.1 | 0.406232 |
MA0059.1 | 0.404929 |
MA0060.1 | 0.224688 |
MA0061.1 | 0.198335 |
MA0063.1 | 0 |
MA0066.1 | 0.607474 |
MA0067.1 | 1.29359 |
MA0068.1 | 0.162298 |
MA0069.1 | 0.958358 |
MA0070.1 | 0.947018 |
MA0071.1 | 0.567661 |
MA0072.1 | 0.942461 |
MA0073.1 | 0.000265001 |
MA0074.1 | 0.60198 |
MA0076.1 | 0.422297 |
MA0077.1 | 0.934645 |
MA0078.1 | 1.67751 |
MA0081.1 | 0.405093 |
MA0083.1 | 0.980893 |
MA0084.1 | 1.48179 |
MA0087.1 | 0.939982 |
MA0088.1 | 0.0723293 |
MA0089.1 | 0 |
MA0090.1 | 0.436918 |
MA0091.1 | 0.505453 |
MA0092.1 | 1.17914 |
MA0093.1 | 0.344385 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.621149 |
MA0101.1 | 0.347695 |
MA0103.1 | 0.332048 |
MA0105.1 | 0.104569 |
MA0106.1 | 0.648997 |
MA0107.1 | 0.274127 |
MA0108.2 | 0.806528 |
MA0109.1 | 0 |
MA0111.1 | 0.45062 |
MA0113.1 | 0.665691 |
MA0114.1 | 0.269076 |
MA0115.1 | 1.21667 |
MA0116.1 | 0.760835 |
MA0117.1 | 1.01134 |
MA0119.1 | 0.388712 |
MA0122.1 | 1.03753 |
MA0124.1 | 1.17486 |
MA0125.1 | 1.0901 |
MA0130.1 | 0 |
MA0131.1 | 0.722072 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 1.00402 |
MA0136.1 | 0.614215 |
MA0139.1 | 0.186511 |
MA0140.1 | 0.564957 |
MA0141.1 | 1.04059 |
MA0142.1 | 0.777365 |
MA0143.1 | 0.66587 |
MA0144.1 | 0.254954 |
MA0145.1 | 0.0807715 |
MA0146.1 | 0.0610556 |
MA0147.1 | 0.281049 |
MA0148.1 | 0.528066 |
MA0149.1 | 0.555119 |
MA0062.2 | 0.193221 |
MA0035.2 | 1.38583 |
MA0039.2 | 0.0170091 |
MA0138.2 | 0.704862 |
MA0002.2 | 0.611548 |
MA0137.2 | 0.36398 |
MA0104.2 | 0.223944 |
MA0047.2 | 0.636643 |
MA0112.2 | 0.0758925 |
MA0065.2 | 0.282161 |
MA0150.1 | 0.430951 |
MA0151.1 | 0 |
MA0152.1 | 0.571637 |
MA0153.1 | 1.07307 |
MA0154.1 | 0.335384 |
MA0155.1 | 0.250175 |
MA0156.1 | 0.36627 |
MA0157.1 | 0.749547 |
MA0158.1 | 0 |
MA0159.1 | 0.281681 |
MA0160.1 | 0.543522 |
MA0161.1 | 0 |
MA0162.1 | 0.25944 |
MA0163.1 | 0.0167306 |
MA0164.1 | 0.678332 |
MA0080.2 | 0.344472 |
MA0018.2 | 0.650405 |
MA0099.2 | 0.572 |
MA0079.2 | 9.11084e-05 |
MA0102.2 | 1.51913 |
MA0258.1 | 0.245543 |
MA0259.1 | 0.289405 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
BATF#10538 | 3 | 10.4390579109873 | 0.0021372507929898 | 0.0123499134430155 |
IRF4#3662 | 3 | 9.39193400860463 | 0.00289381368834148 | 0.0156456493139046 |
MEF2A#4205 | 3 | 8.03281324699031 | 0.00451639783467502 | 0.0213549471865096 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.